doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

    Pharmacy and drugs: news

1 - 20 of 601 <<previous | next>>

Senate HELP Committee Passes Bill To Allow FDA Approval Of Generic Versions Of Biotechnology Medications
The Senate Health, Education, Labor and Pensions Committee on Wednesday unanimously approved legislation (S 1695) that would create a regulatory pathway for the approval of generic versions of biotechnology drugs, the Newark Star-Ledger reports.

2007-07-02 04:00

Newspapers Examine Pharmaceutical Companies' Influence On Physicians
Newspapers on Wednesday examined issues related to the relationship between pharmaceutical companies and physicians. Summaries of the articles appear below. Gifts: Psychiatrists in Vermont earn more money from pharmaceutical companies than other medical specialists, according to a report released on Tuesday by the state, the

2007-06-29 16:00

GPhA Statement On Sens. Kennedy-Enzi-Clinton-Hatch Biogenerics Legislation
Generic Pharmaceutical Association (GPhA) President and CEO Kathleen Jaeger yesterday released the following statement regarding legislation crafted by Senators Edward Kennedy, Michael Enzi, Hillary Clinton, and Orrin Hatch that would authorize the Food and Drug Administration to

2007-06-29 03:00

Kohl Examines Drug Industry Practice Of Providing Payments To Doctors, Influencing Prescribing Behaviors, USA
Senate Special Committee on Aging Chairman Herb Kohl (D-WI) held a hearing to examine the pharmaceutical industry's costly practice of providing payments and gifts to doctors, and to consider what kind of influence this wields over some of our nation's physicians. It is estimated that drug companies spend 19 billion dollars annually on doctors in the form of lecture honoraria and conference registration fees, research grants, trips, meals, drug samples, and other freebies.

2007-06-29 03:00

U.S. Supreme Court Refuses Case Alleging AstraZeneca, Barr Conspired To Monopolize Market For Breast Cancer Drug Tamoxifen
The U.S. Supreme Court on Monday refused to consider a case alleging that AstraZeneca and Barr Laboratories conspired to delay marketing of tamoxifen so as to maintain a monopoly for Nolvadex, AstraZeneca's brand name version of the drug, Dow Jones reports (Anderson, Dow Jones, 6/25).

2007-06-29 03:00

Prescription Drug Reimportation Opponents, Supporters Discuss Issue At PhRMA Briefing
A congressional staff briefing on Monday by the Pharmaceutical Research and Manufacturers of America addressed drug reimportation "in anticipation that lawmakers will try to legalize low-cost drug purchases from abroad by attaching it to must-pass legislation," CongressDaily reports. At the briefing, titled "Know the Threat Behind Importation," Peter Pitts, president of the

2007-06-28 06:00

10,200 Eight-Minute Meetings Symbolize Power And Value Of National Association Of Chain Drug Stores Marketplace, USA
With more than 10,200 "Meet the Market" face-to-face pre-arranged appointments under the belt, including 1,500 of these appointments held for the first time on the exhibit floor, the 2007 NACDS Marketplace Conference is off to a sizzling start. The new and sparkling, state-of-the-art Boston Convention & Exhibition Center is an appropriate setting for one of the best-attended, highly energetic Marketplace Conferences ever.

2007-06-28 03:00

Extending The Half-Life Of Novel And Existing Protein Drugs - Innovative Biopharmaceutical Company, PolyTherics, Raises Over 2 Million Pounds
Imperial Innovations Group plc, the technology commercialisation and investment company (AIM: IVO), Longbow Capital, which focuses on healthcare and technology investments and The Capital Fund, the 50 million pounds Regional Venture Capital Fund for London, today announce that they have completed an investment round of 2.3 million pounds in PolyTherics Limited ('PolyTherics'), an innovative biopharmaceutical company. Longbow Capital's private client base invested 1.

2007-06-28 03:00

Modified Mushrooms May Yield Human Drugs
Mushrooms might serve as biofactories for the production of various beneficial human drugs, according to plant pathologists who have inserted new genes into mushrooms."There has always been a recognized potential of the mushroom as being a choice platform for the mass production of commercially valuable proteins," said Charles Peter Romaine, who holds the John B. Swayne Chair in spawn science and professor of plant pathology at Penn State.

2007-06-27 05:00

Group Of Senators Reaches Bipartisan Agreement On Legislation That Would Allow FDA To Approve Generic Biotechnology Drugs
Senate Health, Education, Labor and Pensions Committee Chair Edward Kennedy (D-Mass.) and Sens. Hillary Rodham Clinton (D-N.Y.), Mike Enzi (R-Wyo.) and Orrin Hatch (R-Utah) on Friday announced an agreement on legislation that would allow FDA to approve generic versions of biotechnology drugs, CongressDaily reports (CongressDaily, 6/25).

2007-06-27 04:00

Report Examines Programs That Would Give HIV-Positive People Access To New Drugs Before Final Federal Approval
"Rethinking the Approach to Expanded Access Programs," Forum for Collaborative HIV Research: The report says that reform of expanded access programs that allow HIV-positive people to take new drugs before final federal approval is needed.

2007-06-26 21:00

House Committee Passes Prescription Drug User Fee Act Reauthorization Legislation
The House Energy and Commerce Committee on Thursday voted 39-0 to approve nine bills that would expand FDA's authority to regulate prescription drug safety and increase user fees paid by drug and medical device companies, Dow Jones reports. The legislation would reauthorize the Prescription Drug User Fee Act, which expires Sept. 30.

2007-06-26 07:00

New Trade Agreement Language To Allow Developing Countries More Flexibility In Circumventing Drug Patents, Other Restrictions
Democratic lawmakers and U.S. trade officials are in the final stages of negotiation over language to be added to international free trade agreements that would allow developing countries more flexibility in circumventing drug patents and other restrictions on pharmaceuticals, sources said recently, CongressDaily reports.

2007-06-26 06:00

Department Of Health, Goldshield Settlement, UK
The Department of Health and Goldshield Group Plc, Goldshield Pharmaceuticals Ltd and Forley Generics Limited ("Goldshield") are pleased to jointly announce settlement of the claims brought against Goldshield for alleged anti-competitive cartel conduct in connection with the supply to the NHS of generic drugs.

2007-06-26 03:00

Meeting Highlights From The Committee For Medicinal Products For Human Use, 18-21 June 2007, Europe Positive Opinions
The European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has adopted eleven positive opinions, three of which relate to similar biological medicinal products, recommending the granting of a marketing authorisation for the following medicinal products: * Atriance (nelarabine), from Glaxo Group Limited, for the treatment of T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic leukaemia (T-LBL) of patients in second relapse.

2007-06-26 03:00

Glide Pharma Is Overall Winner Of Prestigious 2007 Medical Futures Innovation Awards
Glide Pharma, the specialty pharmaceutical company developing products based on its innovative needle-free drug delivery system, has won the Best Business Award at the 2007 Medical Futures Innovation Awards. The Awards are widely regarded as the healthcare industry's Oscars and this year's competition attracted a record number of over 500 entries. The Best Business Award is given to the overall winner from among the 25 award winners.

2007-06-26 03:00

AMA Calls For Investigation Of Store-Based Health Clinics
The American Medical Association (AMA) announced today that it would call for investigations into potential conflicts of interest posed by joint ventures between store-based health clinics and pharmacy chains. The AMA's call for investigations was driven by retailers who have stated that store-based health clinics help drive additional store traffic, which can increase sales of lucrative prescription drugs and other non-health related products.

2007-06-26 02:00

HIV-Positive People In Zambia React To Recall Of Roche Antiretroviral Viracept
The recent recall of Roche's antiretroviral drug Viracept has "created panic" among HIV-positive people taking antiretrovirals in Zambia, some of whom believe that other drugs might not be safe, IRIN News reports (IRIN News, 6/19).The

2007-06-25 12:00

Texas Sues Three Drug Makers Alleging Medicaid Fraud
Texas on Wednesday filed lawsuits against Mylan Laboratories, Sandoz,

2007-06-25 07:00

Federal Judge Rules Three Pharmaceutical Companies Engage In Unfair Practices For Medication Prices
U.S. District Judge Patti Saris in Boston on Thursday ruled that AstraZeneca, Schering-Plough and Bristol-Myers Squibb engaged in unfair and deceptive trade practices related to the prices of some their medications,

2007-06-25 05:00

1 - 20 of 601 <<previous | next>>


© 2006-2007 pharmacy-and-drugs.com. All rights reserved.